Table 1.
Baseline data sheet about KLRB1 express.
| Characteristic | Low expression of KLRB1 | High expression of KLRB1 | p |
|---|---|---|---|
| n | 541 | 542 | |
| Age, n (%) | < 0.001 | ||
| <=60 | 268 (24.7%) | 333 (30.7%) | |
| >60 | 273 (25.2%) | 209 (19.3%) | |
| T stage, n (%) | 0.142 | ||
| T1 | 132 (12.2%) | 145 (13.4%) | |
| T2 | 323 (29.9%) | 306 (28.3%) | |
| T3 | 61 (5.6%) | 78 (7.2%) | |
| T4 | 22 (2%) | 13 (1.2%) | |
| N stage, n (%) | 0.182 | ||
| N0 | 270 (25.4%) | 244 (22.9%) | |
| N1 | 172 (16.2%) | 186 (17.5%) | |
| N2 | 52 (4.9%) | 64 (6%) | |
| N3 | 32 (3%) | 44 (4.1%) | |
| M stage, n (%) | 0.044 | ||
| M0 | 448 (48.6%) | 454 (49.2%) | |
| M1 | 15 (1.6%) | 5 (0.5%) | |
| Pathologic stage, n (%) | 0.025 | ||
| Stage I | 86 (8.1%) | 95 (9%) | |
| Stage II | 323 (30.5%) | 296 (27.9%) | |
| Stage III | 105 (9.9%) | 137 (12.9%) | |
| Stage IV | 13 (1.2%) | 5 (0.5%) | |
| Histological type, n (%) | < 0.001 | ||
| Infiltrating Ductal Carcinoma | 416 (42.6%) | 356 (36.4%) | |
| Infiltrating Lobular Carcinoma | 66 (6.8%) | 139 (14.2%) | |
| ER status, n (%) | 0.021 | ||
| Negative | 102 (9.9%) | 138 (13.3%) | |
| Indeterminate | 1 (0.1%) | 1 (0.1%) | |
| Positive | 410 (39.6%) | 383 (37%) | |
| PR status, n (%) | 0.244 | ||
| Negative | 159 (15.4%) | 183 (17.7%) | |
| Indeterminate | 1 (0.1%) | 3 (0.3%) | |
| Positive | 352 (34%) | 336 (32.5%) | |
| HER2 status, n (%) | 0.236 | ||
| Negative | 256 (35.2%) | 302 (41.5%) | |
| Indeterminate | 6 (0.8%) | 6 (0.8%) | |
| Positive | 84 (11.6%) | 73 (10%) | |
| PAM50, n (%) | < 0.001 | ||
| Normal | 7 (0.6%) | 33 (3%) | |
| LumA | 277 (25.6%) | 285 (26.3%) | |
| LumB | 134 (12.4%) | 70 (6.5%) | |
| Her2 | 36 (3.3%) | 46 (4.2%) | |
| Basal | 87 (8%) | 108 (10%) |